Suvretta Capital Management, LLC Bluebird Bio, Inc. Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $14.1 Million - $26.3 Million	-1,252,575 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $932,144 - $1.14 Million	-51,671 Reduced 3.96%	1,252,575 $40.1 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $14.6 Million - $29.7 Million	877,146 Added 205.37%	1,304,246 $39.3 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $11.7 Million - $16.2 Million	427,100 New	427,100 $18.5 Million

20.2M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $301M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.